Cargando…

A QSAR study on some series of anti­hepatitis B virus (HBV) agents

A quantitative structure­activity relationship (QSAR) study has been made on some series of anti­hepatitis B virus (HBV) agents, namely, a series of novel bis(L­amino acid) ester prodrugs of 9­[2­­(phosphonomethoxy)ethyl]adenine, a similar series of compounds comprising of 2­ amino­6­arylthio­9­[2­(...

Descripción completa

Detalles Bibliográficos
Autores principales: Arora, Preet K, Patil, Vaishali M, Gupta, Satya P
Formato: Texto
Lenguaje:English
Publicado: Biomedical Informatics Publishing Group 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951641/
https://www.ncbi.nlm.nih.gov/pubmed/20975892
_version_ 1782187717977702400
author Arora, Preet K
Patil, Vaishali M
Gupta, Satya P
author_facet Arora, Preet K
Patil, Vaishali M
Gupta, Satya P
author_sort Arora, Preet K
collection PubMed
description A quantitative structure­activity relationship (QSAR) study has been made on some series of anti­hepatitis B virus (HBV) agents, namely, a series of novel bis(L­amino acid) ester prodrugs of 9­[2­­(phosphonomethoxy)ethyl]adenine, a similar series of compounds comprising of 2­ amino­6­arylthio­9­[2­(phosphonoethoxy)ethyl] purine bis(2,2,2­ trifluoroethyl) esters, and a series of 1­isopropylsulfonyl­2­amine benzimidazoles. In each case significant correlations are found between the anti­HBV potencies and some physicochemical and steric properties of the compounds, indicating that for the first two series the activity is controlled by the hydrophobic and the bulk properties of the molecules and, for the third series, the steric and hydrogen bonding properties of compounds are crucial for their anti­HBV potency.
format Text
id pubmed-2951641
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Biomedical Informatics Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-29516412010-10-25 A QSAR study on some series of anti­hepatitis B virus (HBV) agents Arora, Preet K Patil, Vaishali M Gupta, Satya P Bioinformation Hypothesis A quantitative structure­activity relationship (QSAR) study has been made on some series of anti­hepatitis B virus (HBV) agents, namely, a series of novel bis(L­amino acid) ester prodrugs of 9­[2­­(phosphonomethoxy)ethyl]adenine, a similar series of compounds comprising of 2­ amino­6­arylthio­9­[2­(phosphonoethoxy)ethyl] purine bis(2,2,2­ trifluoroethyl) esters, and a series of 1­isopropylsulfonyl­2­amine benzimidazoles. In each case significant correlations are found between the anti­HBV potencies and some physicochemical and steric properties of the compounds, indicating that for the first two series the activity is controlled by the hydrophobic and the bulk properties of the molecules and, for the third series, the steric and hydrogen bonding properties of compounds are crucial for their anti­HBV potency. Biomedical Informatics Publishing Group 2010-03-31 /pmc/articles/PMC2951641/ /pubmed/20975892 Text en © 2010 Biomedical Informatics Publishing Group This is an open-access article, which permits unrestricted use, distribution, and reproduction in any medium, for non-commercial purposes, provided the original author and source are credited.
spellingShingle Hypothesis
Arora, Preet K
Patil, Vaishali M
Gupta, Satya P
A QSAR study on some series of anti­hepatitis B virus (HBV) agents
title A QSAR study on some series of anti­hepatitis B virus (HBV) agents
title_full A QSAR study on some series of anti­hepatitis B virus (HBV) agents
title_fullStr A QSAR study on some series of anti­hepatitis B virus (HBV) agents
title_full_unstemmed A QSAR study on some series of anti­hepatitis B virus (HBV) agents
title_short A QSAR study on some series of anti­hepatitis B virus (HBV) agents
title_sort qsar study on some series of anti­hepatitis b virus (hbv) agents
topic Hypothesis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951641/
https://www.ncbi.nlm.nih.gov/pubmed/20975892
work_keys_str_mv AT arorapreetk aqsarstudyonsomeseriesofantihepatitisbvirushbvagents
AT patilvaishalim aqsarstudyonsomeseriesofantihepatitisbvirushbvagents
AT guptasatyap aqsarstudyonsomeseriesofantihepatitisbvirushbvagents
AT arorapreetk qsarstudyonsomeseriesofantihepatitisbvirushbvagents
AT patilvaishalim qsarstudyonsomeseriesofantihepatitisbvirushbvagents
AT guptasatyap qsarstudyonsomeseriesofantihepatitisbvirushbvagents